1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015

Summary

GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015" provides an overview of Respiratory Syncytial Virus (RSV) Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Respiratory Syncytial Virus (RSV) Infections. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data’s proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table Of Contents

Respiratory Syncytial Virus (RSV) Infections Global Clinical Trials Review, H1, 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 7
Respiratory Syncytial Virus (RSV) Infections 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials and Average Enrollment by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Five Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by G7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 16
Clinical Trials by Phase in G7 Countries 17
Clinical Trials in G7 Countries by Trial Status 18
Clinical Trials by E7 Countries: Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials 19
Clinical Trials by Phase in E7 Countries 20
Clinical Trials in E7 Countries by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Clinical Trials by End Point Status 25
Unaccomplished Trials of Respiratory Syncytial Virus (RSV) Infections 26
Subjects Recruited Over a Period of Time 29
Clinical Trials by Sponsor Type 30
Prominent Sponsors 31
Top Companies Participating in Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials 32
Prominent Drugs 33
Latest Clinical Trials News on Respiratory Syncytial Virus (RSV) Infections 34
Apr 21, 2015: Advanced Inhalation Therapies to Present AIT-RSV Clinical Data at Two Upcoming Medical Meetings 34
Apr 07, 2015: ADMA Biologics Announces Data to be Presented at the Clinical Immunology Society 2015 Annual Meeting 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
AstraZeneca Plc 35
Clinical Trial Overview of AstraZeneca Plc 35
Novavax, Inc. 38
Clinical Trial Overview of Novavax, Inc. 38
Johnson and Johnson 39
Clinical Trial Overview of Johnson and Johnson 39
Gilead Sciences, Inc. 40
Clinical Trial Overview of Gilead Sciences, Inc. 40
GlaxoSmithKline Plc 41
Clinical Trial Overview of GlaxoSmithKline Plc 41
AbbVie Inc. 42
Clinical Trial Overview of AbbVie Inc. 42
Alnylam Pharmaceuticals, Inc. 43
Clinical Trial Overview of Alnylam Pharmaceuticals, Inc. 43
Ablynx NV 44
Clinical Trial Overview of Ablynx NV 44
Abbott Laboratories 45
Clinical Trial Overview of Abbott Laboratories 45
Novartis AG 46
Clinical Trial Overview of Novartis AG 46
Clinical Trial Overview of Top Institutes / Government 47
The National Institute of Allergy and Infectious Diseases 47
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 47
Fred Hutchinson Cancer Research Center 48
Clinical Trial Overview of Fred Hutchinson Cancer Research Center 48
Rambam Health Care Campus 49
Clinical Trial Overview of Rambam Health Care Campus 49
VU University Medical Center 50
Clinical Trial Overview of VU University Medical Center 50
Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 51
Clinical Trial Overview of Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi 51
Chinese University of Hong Kong 52
Clinical Trial Overview of Chinese University of Hong Kong 52
Hurley Medical Center 53
Clinical Trial Overview of Hurley Medical Center 53
Memorial Sloan Kettering Cancer Center 54
Clinical Trial Overview of Memorial Sloan Kettering Cancer Center 54
National Institute of Infectious Diseases 55
Clinical Trial Overview of National Institute of Infectious Diseases 55
Netherlands Asthma Foundation 56
Clinical Trial Overview of Netherlands Asthma Foundation 56
Five Key Clinical Profiles 57
Appendix 99
Abbreviations 99
Definitions 99
Research Methodology 100
Secondary Research 100
About GlobalData 101
Contact Us 101
Disclaimer 101
Source 102

List of Tables
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Region, 2015* 8
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2015* 11
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2015* 12
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, North America, Top Countries, 2015* 13
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2015* 14
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2015* 15
Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 16
Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19
Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Phase, 2015* 22
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2015* 23
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Suspended Clinical Trials, 2015* 26
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Withdrawn Clinical Trials, 2015* 27
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Terminated Clinical Trials, 2015* 28
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Respiratory Syncytial Virus (RSV) Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2015* 30
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca Plc, 2015* 35
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novavax, Inc., 2015* 38
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Johnson and Johnson, 2015* 39
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2015* 40
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline Plc, 2015* 41
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by AbbVie Inc., 2015* 42
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Alnylam Pharmaceuticals, Inc., 2015* 43
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Ablynx NV, 2015* 44
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2015* 45
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Novartis AG, 2015* 46
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by The National Institute of Allergy and Infectious Diseases, 2015* 47
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Fred Hutchinson Cancer Research Center, 2015* 48
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2015* 49
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2015* 50
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Azienda Ospedaliera Universitaria di Bologna Policlinico S. Orsola Malpighi, 2015* 51
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Chinese University of Hong Kong, 2015* 52
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Hurley Medical Center, 2015* 53
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Memorial Sloan Kettering Cancer Center, 2015* 54
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Infectious Diseases, 2015* 55
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials Market, Global, Clinical Trials by Netherlands Asthma Foundation, 2015* 56

List of Figures
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Region (%), 2015* 8
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2015* 9
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2015* 10
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2015* 11
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2015* 12
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2015* 13
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2015* 14
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2015* 15
Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2015* 16
Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2015* 17
Respiratory Syncytial Virus (RSV) Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2015* 18
Proportion of Respiratory Syncytial Virus (RSV) Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2015* 19
Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2015* 20
Respiratory Syncytial Virus (RSV) Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2015* 21
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Phase (%), 2015* 22
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2015* 23
Respiratory Syncytial Virus (RSV) Infections Therapeutics, Global, Clinical Trials by Trial Status, 2015* 24
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, by End Point Status, 2015* 25
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2010-2014 29
Respiratory Syncytial Virus (RSV) Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2015* 30
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2015* 31
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2015* 32
Respiratory Syncytial Virus (RSV) Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2015* 33
GlobalData Methodology 100

Companies Mentioned
AstraZeneca Plc
Novavax, Inc.
Johnson and Johnson
Gilead Sciences, Inc.
GlaxoSmithKline Plc
AbbVie Inc.
Alnylam Pharmaceuticals, Inc.
Ablynx NV
Abbott Laboratories
Novartis AG

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.